Evusheld, aggressive therapy may reduce COVID-19 severity in patients on B-cell depletion
Pre-exposure prophylaxis with Evusheld, combined with aggressive outpatient treatment, may reduce COVID-19 severity in patients with immune-mediated inflammatory disease on B-cell depletion, according to a letter published in RMB Open. “It is well-known that this group of patients is at very high risk for severe COVID and death, even when fully vaccinated, and it has become clear that more